During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Rentschler Biopharma, a global CDMO for biopharmaceuticals, says it has reached important milestones in human resources, the area it considers most important for its future direction and growth.
During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel. More than 200 of the hires are located in Germany, with about 80 in the US, and more than ten hires at the company’s cell and gene therapy facility in the UK. These figures represent an overall growth rate of 30% in the last two years alone.
Dr Frank Mathias, CEO of Rentschler Biopharma, said: “We can provide machines, bioreactors, software infrastructure and buildings. But at the end of the day, it is the employees who bring our value chain to life. Despite the challenges of the pandemic, we were able to, for example, contribute to the production of a vaccine against COVID-19 at an unprecedented speed and with the highest quality.”
Diana Wiedmann, Senior VP Human Relations, added: “People are at the center of our corporate culture and values. Our employees are the key to our success, and only together will we find solutions to the challenges we are given. For us, together means collaboratively, across departments and hierarchies, as well as in close partnership with clients.”